NASDAQ:EVGN - Evogene Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Evogene Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.50 +0.18 (+13.64 %) (As of 12/13/2019 03:26 AM ET) Add Compare Today's Range$1.41Now: $1.50▼$1.5150-Day Range$1.28MA: $1.47▼$1.6952-Week Range$1.26Now: $1.50▼$2.65Volume10,200 shsAverage Volume18,629 shsMarket Capitalization$38.63 millionP/E RatioN/ADividend YieldN/ABeta1.2 ProfileAdvanced ChartEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Evogene Ltd., a biotechnology company, engages in developing various products for various life science markets through the use of computational predictive biology platform in the United States, Germany, and internationally. It discovers and develops products in various areas, including ag-chemicals, ag-biologicals, seed traits, integrated castor oil ag-solutions, and human microbiome-based therapeutics. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Agricultural chemicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EVGN Previous Symbol CUSIPN/A CIK1574565 Webhttp://www.evogene.com/ Phone972-8931-1900Debt Debt-to-Equity Ratio0.03 Current Ratio11.38 Quick Ratio11.38Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.75 million Price / Sales22.07 Cash FlowN/A Price / Cash FlowN/A Book Value$1.95 per share Price / Book0.77Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-20,760,000.00 Net Margins-1,402.12% Return on Equity-34.62% Return on Assets-28.97%Miscellaneous EmployeesN/A Outstanding Shares25,754,000Market Cap$38.63 million Next Earnings Date3/11/2020 (Estimated) OptionableNot Optionable Receive EVGN News and Ratings via Email Sign-up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:EVGN Rates by TradingView Evogene (NASDAQ:EVGN) Frequently Asked Questions What is Evogene's stock symbol? Evogene trades on the NASDAQ under the ticker symbol "EVGN." How were Evogene's earnings last quarter? Evogene Ltd (NASDAQ:EVGN) announced its quarterly earnings results on Tuesday, May, 29th. The biotechnology company reported ($0.21) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.19) by $0.02. The biotechnology company earned $0.37 million during the quarter. Evogene had a negative net margin of 1,402.12% and a negative return on equity of 34.62%. View Evogene's Earnings History. When is Evogene's next earnings date? Evogene is scheduled to release their next quarterly earnings announcement on Wednesday, March 11th 2020. View Earnings Estimates for Evogene. Has Evogene been receiving favorable news coverage? News stories about EVGN stock have trended neutral on Friday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Evogene earned a media sentiment score of 0.4 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Evogene. Are investors shorting Evogene? Evogene saw a decrease in short interest during the month of November. As of November 15th, there was short interest totalling 8,100 shares, a decrease of 8.0% from the October 31st total of 8,800 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio is currently 1.4 days. Approximately 0.0% of the shares of the stock are short sold. View Evogene's Current Options Chain. Who are some of Evogene's key competitors? Some companies that are related to Evogene include Wynnstay Group (WYN), Arcadia Biosciences (RKDA), China Green Agriculture (CGA), Eden Research (EDEN), SenesTech (SNES), Bion Environmental Technologies (BNET), Kiwa Bio-Tech Products Group (KWBT) and Cavitation Technologies (CVAT). What other stocks do shareholders of Evogene own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evogene investors own include Galmed Pharmaceuticals (GLMD), Portola Pharmaceuticals (PTLA), THERAPIX BIOSCI/S (TRPX), Teva Pharmaceutical Industries (TEVA), BIOLINERX LTD/S (BLRX), Cara Therapeutics (CARA), Elbit Systems (ESLT), Nightstar Therapeutics (NITE), Novavax (NVAX) and SCYNEXIS (SCYX). Who are Evogene's key executives? Evogene's management team includes the folowing people: Mr. Ofer Haviv, CEO & Pres (Age 53)Ms. Dorit Kreiner, Interim Chief Financial OfficerMr. Mark Kapel, Exec. VP of Technology (Age 42)Dr. Eyal Emmanuel, Chief Scientific Officer (Age 46)Ms. Sigal Fattal, Exec. Officer (Age 48) Who are Evogene's major shareholders? Evogene's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Phoenix Holdings Ltd. (1.02%). Which institutional investors are buying Evogene stock? EVGN stock was purchased by a variety of institutional investors in the last quarter, including Phoenix Holdings Ltd.. How do I buy shares of Evogene? Shares of EVGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Evogene's stock price today? One share of EVGN stock can currently be purchased for approximately $1.50. How big of a company is Evogene? Evogene has a market capitalization of $38.63 million and generates $1.75 million in revenue each year. View Additional Information About Evogene. What is Evogene's official website? The official website for Evogene is http://www.evogene.com/. How can I contact Evogene? Evogene's mailing address is 13 GAD FEINSTEIN STREET PARK REHOVOT P.O.B 2100, REHOVOT L3, 76121. The biotechnology company can be reached via phone at 972-8931-1900 or via email at [email protected] MarketBeat Community Rating for Evogene (NASDAQ EVGN)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 196 (Vote Outperform)Underperform Votes: 237 (Vote Underperform)Total Votes: 433MarketBeat's community ratings are surveys of what our community members think about Evogene and other stocks. Vote "Outperform" if you believe EVGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVGN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/13/2019 by MarketBeat.com StaffFeatured Article: Do investors pay a separate front-end load every time they buy additional shares?
